Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days In Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Pharmacokinetically Similar to Q6 Hour Dosing in the Pediatric Population

Saved in:

Bibliographic Details
Published in	Biology of blood and marrow transplantation Vol. 15; no. 2; p. 74
Main Authors	Waxman, I, Milone, M.C, Bhatia, M, Shaw, L, Moore, V, Tallamy, B, Militano, O, Garvin, J.H, George, D, Bradley, M.B, Satwani, P, Schwartz, J, Wolownik, K, Foley, S, Hawks, R, Baxter-Lowe, L.A, van de Ven, C, Cairo, M.S
Format	Journal Article
Language	English
Published	Elsevier Inc 01.02.2009
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	1083-8791 1523-6536
DOI:	10.1016/j.bbmt.2008.12.229